Podcast Transcript:

Hello and Welcome to News From The Future, spoken by the eleven labs audio clone of Dr Catherine Ball.

In this new short series we will be focussing on Sleep.

We all do it, and we all recognise when we have not had enough of it.

Dr Cath’s new book The Future of Sleep is out now and available globally in paperback, audiobook, and ebook.

We think you’ll get something life changing from it.

Today we are talking about something a bit controversial - New drugs to prevent Alzheimers that are enhancing the glymphatic system.

Enjoy!

A fascinating breakthrough in neuroscience has identified a combination of two drugs that could significantly enhance the brain’s glymphatic system. This system, often described as the brain’s waste-disposal mechanism, plays a critical role in clearing out harmful proteins and toxins that accumulate over time. These proteins, such as beta-amyloid and tau, are strongly associated with the development of Alzheimer’s disease. For the first time, researchers have pinpointed drugs that can specifically target and boost this system, offering a potential way to delay the onset of Alzheimer’s by several years.

The two drugs at the center of this discovery are not new; they are existing therapies repurposed for this groundbreaking application. One is a sedative commonly used for its calming effects, while the other is a medication designed to prevent dangerously low blood pressure. When used together, these drugs appear to enhance the glymphatic system’s ability to remove waste from the brain, including the proteins linked to Alzheimer’s. This synergy between the two drugs is what makes the approach so promising, as it not only improves waste clearance but does so safely and effectively.

The glymphatic system itself is a relatively recent focus in neuroscience. Unlike the lymphatic system, which clears waste from other parts of the body, the glymphatic system operates exclusively within the brain. It relies on cerebrospinal fluid to flush out metabolic waste, particularly during sleep. This is one of the reasons why quality sleep is often emphasized as a cornerstone of good brain health. By targeting this system pharmacologically, researchers are opening up new possibilities for treating and potentially preventing neurodegenerative diseases.

One of the most exciting aspects of this discovery is the potential to delay the onset of Alzheimer’s disease. Current findings suggest that the use of these drugs could push back the disease’s onset by up to seven years. This is a significant improvement, considering the profound impact Alzheimer’s has on individuals, families, and healthcare systems worldwide. Even a modest delay in the onset of symptoms could translate into a better quality of life for millions of people and a substantial reduction in the economic and emotional burden of the disease.

The implications of this research extend beyond those already at risk for or suffering from Alzheimer’s. Shiju Gu, a researcher at Harvard University who was not involved in the study, highlighted the broader potential of this discovery. According to Gu, enhancing the glymphatic system could benefit not only individuals with neurodegenerative diseases but also healthy people looking to optimize their brain function. This raises intriguing possibilities about the role these drugs could play in improving overall cognitive performance and brain health.

The discovery also underscores the importance of understanding the glymphatic system in greater detail. Scientists have long known that the buildup of beta-amyloid and tau proteins in the brain is a hallmark of Alzheimer’s disease. These proteins form plaques and tangles that disrupt communication between neurons, leading to cognitive decline. By enhancing the brain’s natural ability to clear out these proteins, the newly identified drugs could address one of the root causes of the disease rather than merely treating its symptoms.

While the findings are undoubtedly promising, it is important to approach them with cautious optimism. The research is still in its early stages, and further studies will be needed to confirm the safety and efficacy of these drugs in larger and more diverse populations. Researchers will also need to determine the optimal dosages and treatment regimens to maximize the benefits while minimizing potential side effects. These are critical steps that must be taken before the drugs can be made widely available.

The potential applications of this discovery are vast and varied. Beyond Alzheimer’s, the ability to enhance the glymphatic system could have implications for other brain-related conditions, such as traumatic brain injuries, strokes, and even age-related cognitive decline. It also raises questions about whether these drugs could be used preventatively in healthy individuals to maintain and improve brain function as they age. The answers to these questions could pave the way for a new era in brain health and medicine.

One of the most compelling aspects of this research is its focus on prevention rather than treatment. Current therapies for Alzheimer’s and other neurodegenerative diseases are largely aimed at managing symptoms rather than addressing the underlying causes. By targeting the glymphatic system, these drugs offer a new approach that could delay or even prevent the onset of these diseases. This represents a paradigm shift in how we think about and approach brain health.

In summary, the identification of drugs that can enhance the brain’s glymphatic system represents a major milestone in neuroscience. By improving the brain’s ability to clear out harmful proteins, these drugs offer hope for delaying the onset of Alzheimer’s disease and potentially enhancing overall brain function. While more research is needed to fully understand their potential, the findings are a significant step forward in the fight against neurodegenerative diseases. This discovery not only opens up new possibilities for treatment but also underscores the importance of continued research into the glymphatic system and its role in maintaining brain health.

Please share this podcast with anyone you know who sleeps.

Thank you for supporting my work.

Please follow me on LinkedIn or subscribe to my substack for more News From The Future

And please buy my book: The Future of Sleep from your favourite online bookshop or my website’s book shop.

Thank you.

Thanks for reading "News From The Future" with Dr Catherine Ball! This post is public so feel free to share it with anyone you know who sleeps.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drcatherineball.substack.com/subscribe